Your email has been successfully added to our mailing list.

×
1.05034293696797E-05 9.45308643272363E-05 0.00141796296490807 0.00124990809499295 0.00241578875502847 -0.00103983950759924 0.00203766529771964 0.00861281208314508
Stock impact report

Crispr Therapeutics gains amid takeover speculation [Seeking Alpha]

Vertex Pharmaceuticals Incorporated (VRTX) 
Last vertex pharmaceuticals incorporated earnings: 4/29 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.vrtx.com
Company Research Source: Seeking Alpha
Vertex Pharmaceuticals ( VRTX ) is speculated to be the company that has been studying a potential acquisition of Crispr ( CRSP ) since late last year, according to traders, who cited a Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up Show less Read more
Impact Snapshot
Event Time:
VRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VRTX alerts
Opt-in for
VRTX alerts

from News Quantified
Opt-in for
VRTX alerts

from News Quantified